Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy.
about
Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Relationship between 6- and 9- ...... cisplatin-based chemotherapy.
@en
Relationship between 6- and 9- ...... cisplatin-based chemotherapy.
@nl
type
label
Relationship between 6- and 9- ...... cisplatin-based chemotherapy.
@en
Relationship between 6- and 9- ...... cisplatin-based chemotherapy.
@nl
prefLabel
Relationship between 6- and 9- ...... cisplatin-based chemotherapy.
@en
Relationship between 6- and 9- ...... cisplatin-based chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Relationship between 6- and 9- ...... cisplatin-based chemotherapy.
@en
P2093
Aristotle Bamias
Chia-Chi Lin
Erin Moshier
Guru Sonpavde
James Godbold
Matthew D Galsky
Susan Krege
Thorsten Ecke
William K Oh
P2860
P304
P356
10.1002/CNCR.28145
P407
P577
2013-05-29T00:00:00Z